From BACE1 Inhibitor to Multifunctionality of tryptoline and tryptamine triazole derivatives for alzheimer's disease

Jutamas Jiaranaikulwanitch, Piyarat Govitrapong, Valery V. Fokin, Opa Vajragupta

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Efforts to discover new drugs for Alzheimer's disease emphasizing multiple targets was conducted seeking to inhibit amyloid oligomer formation and to prevent radical formation. The tryptoline and tryptamine cores of BACE1 inhibitors previously identified by virtual screening were modified in silico for additional modes of action. These core structures were readily linked to different side chains using 1,2,3-triazole rings as bridges by copper catalyzed azide-alkyne cycloaddition reactions. Three compounds among the sixteen designed compounds exerted multifunctional activities including β-secretase inhibitory action, anti-amyloid aggregation, metal chelating and antioxidant effects at micromolar levels. The neuroprotective effects of the multifunctional compounds 6h, 12c and 12h on Aβ1-42 induced neuronal cell death at 1 ?M were significantly greater than those of the potent single target compound, BACE1 inhibitor IV and were comparable to curcumin. The observed synergistic effect resulting from the reduction of the Aβ1-42 neurotoxicity cascade substantiates the validity of our multifunctional strategy in drug discovery for Alzheimer's disease.

Original languageEnglish
Pages (from-to)8312-8333
Number of pages22
JournalMolecules
Volume17
Issue number7
DOIs
Publication statusPublished - Jul 2012
Externally publishedYes

Fingerprint

tryptamines
Triazoles
Amyloid
inhibitors
Alzheimer Disease
Derivatives
Amyloid Precursor Protein Secretases
Curcumin
Alkynes
Azides
Cycloaddition
Cycloaddition Reaction
drugs
Neuroprotective Agents
Cell death
Drug Discovery
Chelation
Oligomers
Computer Simulation
Copper

Keywords

  • Anti-amyloid aggregation
  • Antioxidant
  • BACE1 inhibitor
  • Chelator
  • Multifunction drugs
  • Neuroprotection

ASJC Scopus subject areas

  • Organic Chemistry
  • Medicine(all)

Cite this

From BACE1 Inhibitor to Multifunctionality of tryptoline and tryptamine triazole derivatives for alzheimer's disease. / Jiaranaikulwanitch, Jutamas; Govitrapong, Piyarat; Fokin, Valery V.; Vajragupta, Opa.

In: Molecules, Vol. 17, No. 7, 07.2012, p. 8312-8333.

Research output: Contribution to journalArticle

Jiaranaikulwanitch, Jutamas ; Govitrapong, Piyarat ; Fokin, Valery V. ; Vajragupta, Opa. / From BACE1 Inhibitor to Multifunctionality of tryptoline and tryptamine triazole derivatives for alzheimer's disease. In: Molecules. 2012 ; Vol. 17, No. 7. pp. 8312-8333.
@article{080a1aa95d474963a3eff0fd25f6f5ba,
title = "From BACE1 Inhibitor to Multifunctionality of tryptoline and tryptamine triazole derivatives for alzheimer's disease",
abstract = "Efforts to discover new drugs for Alzheimer's disease emphasizing multiple targets was conducted seeking to inhibit amyloid oligomer formation and to prevent radical formation. The tryptoline and tryptamine cores of BACE1 inhibitors previously identified by virtual screening were modified in silico for additional modes of action. These core structures were readily linked to different side chains using 1,2,3-triazole rings as bridges by copper catalyzed azide-alkyne cycloaddition reactions. Three compounds among the sixteen designed compounds exerted multifunctional activities including β-secretase inhibitory action, anti-amyloid aggregation, metal chelating and antioxidant effects at micromolar levels. The neuroprotective effects of the multifunctional compounds 6h, 12c and 12h on Aβ1-42 induced neuronal cell death at 1 ?M were significantly greater than those of the potent single target compound, BACE1 inhibitor IV and were comparable to curcumin. The observed synergistic effect resulting from the reduction of the Aβ1-42 neurotoxicity cascade substantiates the validity of our multifunctional strategy in drug discovery for Alzheimer's disease.",
keywords = "Anti-amyloid aggregation, Antioxidant, BACE1 inhibitor, Chelator, Multifunction drugs, Neuroprotection",
author = "Jutamas Jiaranaikulwanitch and Piyarat Govitrapong and Fokin, {Valery V.} and Opa Vajragupta",
year = "2012",
month = "7",
doi = "10.3390/molecules17078312",
language = "English",
volume = "17",
pages = "8312--8333",
journal = "Molecules",
issn = "1420-3049",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "7",

}

TY - JOUR

T1 - From BACE1 Inhibitor to Multifunctionality of tryptoline and tryptamine triazole derivatives for alzheimer's disease

AU - Jiaranaikulwanitch, Jutamas

AU - Govitrapong, Piyarat

AU - Fokin, Valery V.

AU - Vajragupta, Opa

PY - 2012/7

Y1 - 2012/7

N2 - Efforts to discover new drugs for Alzheimer's disease emphasizing multiple targets was conducted seeking to inhibit amyloid oligomer formation and to prevent radical formation. The tryptoline and tryptamine cores of BACE1 inhibitors previously identified by virtual screening were modified in silico for additional modes of action. These core structures were readily linked to different side chains using 1,2,3-triazole rings as bridges by copper catalyzed azide-alkyne cycloaddition reactions. Three compounds among the sixteen designed compounds exerted multifunctional activities including β-secretase inhibitory action, anti-amyloid aggregation, metal chelating and antioxidant effects at micromolar levels. The neuroprotective effects of the multifunctional compounds 6h, 12c and 12h on Aβ1-42 induced neuronal cell death at 1 ?M were significantly greater than those of the potent single target compound, BACE1 inhibitor IV and were comparable to curcumin. The observed synergistic effect resulting from the reduction of the Aβ1-42 neurotoxicity cascade substantiates the validity of our multifunctional strategy in drug discovery for Alzheimer's disease.

AB - Efforts to discover new drugs for Alzheimer's disease emphasizing multiple targets was conducted seeking to inhibit amyloid oligomer formation and to prevent radical formation. The tryptoline and tryptamine cores of BACE1 inhibitors previously identified by virtual screening were modified in silico for additional modes of action. These core structures were readily linked to different side chains using 1,2,3-triazole rings as bridges by copper catalyzed azide-alkyne cycloaddition reactions. Three compounds among the sixteen designed compounds exerted multifunctional activities including β-secretase inhibitory action, anti-amyloid aggregation, metal chelating and antioxidant effects at micromolar levels. The neuroprotective effects of the multifunctional compounds 6h, 12c and 12h on Aβ1-42 induced neuronal cell death at 1 ?M were significantly greater than those of the potent single target compound, BACE1 inhibitor IV and were comparable to curcumin. The observed synergistic effect resulting from the reduction of the Aβ1-42 neurotoxicity cascade substantiates the validity of our multifunctional strategy in drug discovery for Alzheimer's disease.

KW - Anti-amyloid aggregation

KW - Antioxidant

KW - BACE1 inhibitor

KW - Chelator

KW - Multifunction drugs

KW - Neuroprotection

UR - http://www.scopus.com/inward/record.url?scp=84864614799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864614799&partnerID=8YFLogxK

U2 - 10.3390/molecules17078312

DO - 10.3390/molecules17078312

M3 - Article

C2 - 22781443

AN - SCOPUS:84864614799

VL - 17

SP - 8312

EP - 8333

JO - Molecules

JF - Molecules

SN - 1420-3049

IS - 7

ER -